NuVasive revenue spikes 7.2% in Q3: 4 things to know

Spinal Tech

NuVasive posted $290.8 million in total revenue for the third quarter, an increase of 7.2 percent year-over-year.

Four things to know:

1. The company's gross profit increased 8.5 percent to $213.8 million but net income decreased 31 percent to $11 million for the same period last year.

2. Product revenue increased 7.5 percent to $260.1 million compared to the third quarter of last year.

3. NuVasive's total operating expenses rose $4.1 million to $183.2 million year-over-year.

4. NuVasive CEO J. Christopher Barry said the company's "margin expansion demonstrates the ability to improve profitability" and it is "raising full-year 2019 financial guidance to reflect continued growth and confidence in the business."

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Webinars

Featured Podcast

Featured Whitepapers